Z
6.97
0.21 (3.11%)
| Penutupan Terdahulu | 6.76 |
| Buka | 6.55 |
| Jumlah Dagangan | 343,692 |
| Purata Dagangan (3B) | 687,700 |
| Modal Pasaran | 661,318,528 |
| Harga / Buku (P/B) | 5.93 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 24 Mar 2026 |
| EPS Cair (TTM) | -0.770 |
| Nisbah Semasa (MRQ) | 8.14 |
| Aliran Tunai Operasi (OCF TTM) | -34.16 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -17.40 M |
| Pulangan Atas Aset (ROA TTM) | -31.40% |
| Pulangan Atas Ekuiti (ROE TTM) | -55.05% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Zura Bio Limited | Menaik | Bercampur |
AISkor Stockmoo
-0.4
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 0.5 |
| Purata | -0.38 |
|
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 29.16% |
| % Dimiliki oleh Institusi | 70.62% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Great Point Partners I Lp | 31 Dec 2025 | 3,815,930 |
| Julat 52 Minggu | ||
| Median | 15.00 (115.21%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wedbush | 09 Feb 2026 | 15.00 (115.21%) | Beli | 6.27 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Feb 2026 | Pengumuman | Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit |
| 21 Jan 2026 | Pengumuman | Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer |
| 12 Jan 2026 | Pengumuman | Zura Bio Reports Business Updates and Outlook for 2026 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |